Breathe Well Live Well
Lung Disease News |
Tiotropium Therapy Shown As Safe and Effective Treatment for Adolescents with …
Lung Disease News Asthma is a common chronic inflammatory lung disease characterized by airflow obstruction that causes wheezing, shortness of breath, chest tightness and coughing. The respiratory disorder is estimated to affect 27 million individuals in the United States. |
View full post on asthma – Google News
|
Tiotropium safe, effective for asthma in adolescents
Healio “This systematic review of tiotropium for adolescents with symptomatic moderate to severe asthma suggests that tiotropium administered via an inhaler is well tolerated and efficacious as an addition to maintenance treatment with [inhaled … |
View full post on asthma – Google News
Condition: Asthma
Intervention: Drug: MEDI9929 (AMG 157)
Sponsors: MedImmune LLC; Amgen
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Phenotypes of severe asthma among children and adolescents in Brazil: a …
BMC Blogs Network Background The morbidity associated with severe uncontrolled asthma is disproportionately higher in low- and middle-income countries than in high-income countries. The aim of this study was to describe the phenotypic characteristics of difficult-to … |
View full post on asthma – Google News
Lung Disease News |
FDA Rejects GSK's Breo Ellipta Asthma Therapy Use in Adolescents; Adult Use …
Lung Disease News GSK Incruse Ellipta COPD The U.S. Food and Drug Administration (FDA) ruled against the use of GlaxoSmithKline's new drug combination Breo Ellipta in asthma patients between the ages of 12 and 17. However, the Pulmonary-Allergy Drugs Advisory … |
View full post on asthma – Google News
Channel News Asia |
UPDATE 2-FDA panel backs Glaxo asthma drug for adults, not adolescents
Reuters The panel voted 16-4 that Breo Ellipta should be approved for once daily treatment of asthma in adults 18 years and older. It voted 19-1 that the data did not support approval for use in children aged 12 to 17. The FDA is not obliged to follow the … U.S. Panel Backs Glaxo's Breo for Adults With Asthma, Not Kids GSK's Breo for asthma? FDA panel says yes–but only in adults FDA panel backs Glaxo asthma drug for adults, not adolescents |
View full post on asthma – Google News
Channel News Asia |
FDA panel backs Glaxo asthma drug for adults, not adolescents
Reuters The panel voted 16 to 4 that the product, Breo Ellipta, should be approved for once daily treatment of asthma in adults 18 years and older. It voted 19 to 1 that the data did not support approval for use in children aged 12 to 17. The FDA is not … Critical inspection of GlaxoSmithKline plc (ADR) (NYSE:GSK) by FDA … FDA panel backs Glaxo inhaler for adults, not adolescents GSK and Theravance Announce Outcome of US FDA Advisory Committee on … |
View full post on asthma – Google News
Lung Disease News |
Vitamin D Levels Found To Be Lower Among Asthmatic Adolescents
Lung Disease News According to a recent study led by Ourania Kolokotroni from the Cyprus International Institute for Environmental & Public Health in association with Harvard School of Public Health, Cyprus University of Technology, asthmatic young people have lower … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler; Drug: Placebo inhalation powders via ELLIPTA inhaler; Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler; Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler; Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler
Sponsor: GlaxoSmithKline
Not yet recruiting – verified November 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Low asthma medication adherence predictors identified in adolescents
News-Medical.net Inhaled corticosteroid (ICS) adherence among adolescents with asthma is low and is associated with a lack of knowledge about treatment and patients' perceptions about their medicines, show findings of a study published in the Journal of Asthma. |
View full post on asthma – Google News